Small biotech Resonant Sensors Incorporated is a small biotechnology research company with a benchtop, label-free antibody discovery platform. This presents a sales opportunity to position scalable, cost-effective screening solutions to small and emerging biotech firms seeking rapid antibody characterization.

High throughput readiness The ResoSens Ultra-Mab Pro enables rapid, high-throughput antibody characterization in a standard 96-well format, suggesting upsell potential to labs expanding screening campaigns or transitioning from lower-throughput methods to faster, turnkey plate reader workflows.

Custom reagents In addition to instrumentation, RSI offers customized immunotherapy reagents such as peptide/HLA monomers and tetramers, creating cross-sell and partner opportunities with researchers and companies designing personalized or targeted immunotherapies.

Digital and web presence The tech stack includes WordPress, SEO and analytics tooling, indicating potential demand for enhanced digital marketing services, technical content development, and demand-gen support to reach biotech customers and accelerate inbound inquiries.

Growth signals Reported revenue in the 1M–10M range and a focus on expanding benchtop capabilities point to opportunities for channel partnerships, distributor relationships, or collaboration with mid-size CROs seeking ready-to-use antibody discovery platforms.